$node = stdClass Object (
[nid] => [10288]
[vid] => [10346]
[type] => [core]
[status] => [1]
[created] => [1224603333]
[changed] => [1225323779]
[comment] => [2]
[promote] => [0]
[sticky] => [0]
[revision_timestamp] => [1225323779]
[title] => [DRTC Baltimore Transgenic/ES Cell Core]
[body] => [<div class="field field-type-text field-field-center"><div class="field-items"><div class="field-item">DRTC - Johns Hopkins University/University of Maryland</div></div></div><div class="field field-type-text field-field-objectives"><div class="field-items"><div class="field-item"><p><span class="normal"><span>The aim of the Transgenic/ES Cell Core will be to accelerate research programs that depend on the development of genetically altered mouse models, including transgenics, knock-outs, knock-ins, and inducible knock-outs. The goal of the Transgenic/ES Cell core is to enable Baltimore DRTC investigators to efficiently generate genetically altered mice including transgenic, knock-out or knock-in mouse models.</span></span><span></span></p>
<p> </p>
<p><span class="normal"><span>The Transgenic/ES Cell Core objectives:</span></span></p>
<p> </p>
<p><span class="normal"><span>• Provide advice and guidance in the use of transgenic, knock-out and knock-in mice for diabetes and diabetes-related research</span></span><span><br /><span class="normal">• Generate transgenic mouse strains</span><br /><span class="normal">• Generate gene knock-out and knock-in mouse strains</span><br /><span class="normal">• Provide embryo freezing and storage capabilities for Investigators</span></span></p>
<p><span class="normal"><span>Frederic Wondisford, MD - Director</span></span><span><br /><span class="normal">Sally Radovick, MD - Co-Director</span></span></p>
<p> </p>
</div></div></div>]
[log] => []
[format] => [0]
[uid] => [5]
[name] => [kristin.abraham]
[picture] => []
[data] => [a:0:{}]
[path] => [core/transgenices-cell-core]
[nodewords] => []
[last_comment_timestamp] => [1224603333]
[last_comment_name] => []
[comment_count] => [0]
[taxonomy] => array (
[35] => stdClass (
[0] => [**Recursion Detected**]
)
)
[files] => []
[field_core_short_name] => array (
[0] => array (
[value] => [Baltimore Transgenic/ES Cell]
)
)
[field_center] => array (
[0] => array (
[value] => [19]
[view] => [DRTC - Johns Hopkins University/University of Maryland]
)
)
[field_objectives] => array (
[0] => array (
[value] => [<p><span class="normal"><span style="font-size: 10pt; font-family: Verdana">The aim of the Transgenic/ES Cell Core will be to accelerate research programs that depend on the development of genetically altered mouse models, including transgenics, knock-outs, knock-ins, and inducible knock-outs. The goal of the Transgenic/ES Cell core is to enable Baltimore DRTC investigators to efficiently generate genetically altered mice including transgenic, knock-out or knock-in mouse models.</span></span><span style="font-size: 10pt; font-family: Verdana"><o:p></o:p></span></p><p> </p><p><span class="normal"><span style="font-size: 10pt; font-family: Verdana">The Transgenic/ES Cell Core objectives:</span></span></p><p> </p><p><span class="normal"><span style="font-size: 10pt; font-family: Verdana">• Provide advice and guidance in the use of transgenic, knock-out and knock-in mice for diabetes and diabetes-related research</span></span><span style="font-size: 10pt; font-family: Verdana"><br /><span class="normal">• Generate transgenic mouse strains</span><br /><span class="normal">• Generate gene knock-out and knock-in mouse strains</span><br /><span class="normal">• Provide embryo freezing and storage capabilities for Investigators</span><o:p></o:p></span></p><p><span class="normal"><span style="font-size: 10pt; font-family: Verdana">Frederic Wondisford, MD - Director</span></span><span style="font-size: 10pt; font-family: Verdana"><br /><span class="normal">Sally Radovick, MD - Co-Director</span><o:p></o:p></span></p><p> </p>]
[format] => [1]
[view] => [<p><span class="normal"><span>The aim of the Transgenic/ES Cell Core will be to accelerate research programs that depend on the development of genetically altered mouse models, including transgenics, knock-outs, knock-ins, and inducible knock-outs. The goal of the Transgenic/ES Cell core is to enable Baltimore DRTC investigators to efficiently generate genetically altered mice including transgenic, knock-out or knock-in mouse models.</span></span><span></span></p>
<p> </p>
<p><span class="normal"><span>The Transgenic/ES Cell Core objectives:</span></span></p>
<p> </p>
<p><span class="normal"><span>• Provide advice and guidance in the use of transgenic, knock-out and knock-in mice for diabetes and diabetes-related research</span></span><span><br /><span class="normal">• Generate transgenic mouse strains</span><br /><span class="normal">• Generate gene knock-out and knock-in mouse strains</span><br /><span class="normal">• Provide embryo freezing and storage capabilities for Investigators</span></span></p>
<p><span class="normal"><span>Frederic Wondisford, MD - Director</span></span><span><br /><span class="normal">Sally Radovick, MD - Co-Director</span></span></p>
<p> </p>
]
)
)
[field_field_core_url] => array (
[0] => array (
[value] => [http://www.hopkinsmedicine.org/drtc/cores/#transgen]
)
)
[field_services] => array (
[0] => array (
[value] => []
[format] => [1]
[view] => []
)
)
[field_content_weight] => array (
[0] => array (
[value] => []
)
)
[page_title] => []
[readmore] => []
[content] => array (
[field_core_short_name] => array (
[#weight] => [-4]
[#value] => []
[#access] => []
)
[field_center] => array (
[#access] => [1]
[#value] => [<div class="field field-type-text field-field-center"><div class="field-items"><div class="field-item">DRTC - Johns Hopkins University/University of Maryland</div></div></div>]
[#weight] => [-3]
[#printed] => [1]
)
[field_objectives] => array (
[#access] => [1]
[#value] => [<div class="field field-type-text field-field-objectives"><div class="field-items"><div class="field-item"><p><span class="normal"><span>The aim of the Transgenic/ES Cell Core will be to accelerate research programs that depend on the development of genetically altered mouse models, including transgenics, knock-outs, knock-ins, and inducible knock-outs. The goal of the Transgenic/ES Cell core is to enable Baltimore DRTC investigators to efficiently generate genetically altered mice including transgenic, knock-out or knock-in mouse models.</span></span><span></span></p>
<p> </p>
<p><span class="normal"><span>The Transgenic/ES Cell Core objectives:</span></span></p>
<p> </p>
<p><span class="normal"><span>• Provide advice and guidance in the use of transgenic, knock-out and knock-in mice for diabetes and diabetes-related research</span></span><span><br /><span class="normal">• Generate transgenic mouse strains</span><br /><span class="normal">• Generate gene knock-out and knock-in mouse strains</span><br /><span class="normal">• Provide embryo freezing and storage capabilities for Investigators</span></span></p>
<p><span class="normal"><span>Frederic Wondisford, MD - Director</span></span><span><br /><span class="normal">Sally Radovick, MD - Co-Director</span></span></p>
<p> </p>
</div></div></div>]
[#weight] => [-3]
[#printed] => [1]
)
[field_field_core_url] => array (
[#weight] => [-2]
[#value] => []
[#access] => []
)
[field_services] => array (
[#access] => [1]
[#value] => []
[#weight] => [-1]
[#printed] => [1]
)
[field_content_weight] => array (
[#weight] => [0]
[#value] => []
[#access] => []
)
[body] => array (
[#weight] => [0]
[#value] => []
[#printed] => [1]
)
[#children] => [<div class="field field-type-text field-field-center"><div class="field-items"><div class="field-item">DRTC - Johns Hopkins University/University of Maryland</div></div></div><div class="field field-type-text field-field-objectives"><div class="field-items"><div class="field-item"><p><span class="normal"><span>The aim of the Transgenic/ES Cell Core will be to accelerate research programs that depend on the development of genetically altered mouse models, including transgenics, knock-outs, knock-ins, and inducible knock-outs. The goal of the Transgenic/ES Cell core is to enable Baltimore DRTC investigators to efficiently generate genetically altered mice including transgenic, knock-out or knock-in mouse models.</span></span><span></span></p>
<p> </p>
<p><span class="normal"><span>The Transgenic/ES Cell Core objectives:</span></span></p>
<p> </p>
<p><span class="normal"><span>• Provide advice and guidance in the use of transgenic, knock-out and knock-in mice for diabetes and diabetes-related research</span></span><span><br /><span class="normal">• Generate transgenic mouse strains</span><br /><span class="normal">• Generate gene knock-out and knock-in mouse strains</span><br /><span class="normal">• Provide embryo freezing and storage capabilities for Investigators</span></span></p>
<p><span class="normal"><span>Frederic Wondisford, MD - Director</span></span><span><br /><span class="normal">Sally Radovick, MD - Co-Director</span></span></p>
<p> </p>
</div></div></div>]
[#printed] => [1]
)
[links] => array (
[comment_forbidden] => array (
[title] => [<a href="/user/login?destination=comment/reply/10288%2523comment-form">Login</a> to post comments]
[html] => [1]
)
)
);